Click Here to return To Results

 

Safety of Antiplatelet Therapy Prior to Intravenous Thrombolysis in Acute Ischemic Stroke Arch Neurol 65:607-611,575, Uyttenboogaart,M.,et al, 2008 See this aricle in Pubmed Article Abstract Despite a higher incidence of SICH, the net benefit of intravenous tissue plasminogen activator therapy for acute ischemic stroke was greater in patients using AP drugs.

Related Tags

(click to filter results - removes previous filter) adverse drug reaction cerebrovascular accident,acute management of cerebrovascular accident,thrombolytic agents in treatment complications fibrinolytic agents fibrinolytic agents,complications iatrogenic neurologic disorders intracerebral hemorrhage platelet inhibiting drugs safety tissue plasminogen activator,intravenous

Click Here to return To Results